The public trading debut of medical supply giant Medline will go down as the biggest global IPO of 2025. That’s impressive in and of itself, but it’s even more impressive given that the company is not ...

India's IPO market soars, but mega deals aren't always safe bets—research before investing in the next big IPO.

Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other ...

Shares of U.S. medical supplies giant Medline jumped in its debut on the Nasdaq on Wednesday after the biggest initial public offering of the year globally. Shares closed up more than 41% at $41 a ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

After a record 2025 with 373 listings raising ₹1.95 trillion, primary market activity slows sharply as subscriptions moderate, small- and mid-cap weakness weighs on sentiment, and analysts flag a ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest. IPO’s portfolio is heavily growth-oriented, with 94% SMID-cap exposure and ...

In pushing ahead with its IPO, both Medline and investors that are supporting the deal upfront are looking past the negative impact of tariffs. Only 16% of Medline’s total cost of goods sold is ...

India’s primary market is beginning to show signs of fatigue after a strong run in 2025, with the recent IPOs of Aye Finance and Clean Max Enviro Energy Solutions failing to fully subscribe, ...